Principal Financial Group
DNTH icon

Principal Financial Group’s Dianthus Therapeutics DNTH Stock Holding History

Principal Financial Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
+3,618
New +$316K ﹤0.01% 2035
2022
Q2 		– Sell
-37,350
Closed -$1.73M – 2540
2022
Q1 		$1.73M Buy
37,350
+58
+0.2% +$3.17K ﹤0.01% 1884
2021
Q4 		$2.64M Buy
37,292
+7,142
+24% +$718K ﹤0.01% 1818
2021
Q3 		$3.51M Buy
30,150
+469
+2% +$54.6K ﹤0.01% 1780
2021
Q2 		$4.64M Buy
29,681
+11,481
+63% +$2.11M ﹤0.01% 1735
2021
Q1 		$3.45M Buy
18,200
+2,337
+15% +$393K ﹤0.01% 1755
2020
Q4 		$1.99M Buy
15,863
+913
+6% +$104K ﹤0.01% 1801
2020
Q3 		$1.63M Buy
14,950
+475
+3% +$56.3K ﹤0.01% 1775
2020
Q2 		$1.74M Buy
14,475
+37
+0.3% +$5.21K ﹤0.01% 1722
2020
Q1 		$1.45M Hold
14,438
– – ﹤0.01% 1670
2019
Q4 		$3.5M Sell
14,438
-16
-0.1% -$2.99K ﹤0.01% 1621
2019
Q3 		$2.37M Sell
14,454
-134
-0.9% -$25.5K ﹤0.01% 1693
2019
Q2 		$3.44M Sell
14,588
-143
-1% -$35.4K ﹤0.01% 1629
2019
Q1 		$3.88M Sell
14,731
-2,144
-13% -$370K ﹤0.01% 1620
2018
Q4 		$1.54M Sell
16,875
-8,816
-34% -$1.2M ﹤0.01% 1749
2018
Q3 		$4.94M Buy
25,691
+76
+0.3% +$16K ﹤0.01% 1610
2018
Q2 		$5.53M Buy
+25,615
New +$5.78M 0.01% 1564

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Principal Financial Group's DNTH Position: Q2 2026 in Review

Principal Financial Group opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 3,618 shares worth $353K. The stake represents ﹤0.01% of the portfolio and ranks #2035 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in DNTH as recently as Q1 2022.

Principal Financial Group first reported a position in DNTH in Q2 2018 and has held it in 17 quarters since. The position peaked at $5.53M in Q2 2018. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Principal Financial Group held 3,618 shares of Dianthus Therapeutics worth $353K as of Q2 2026.
  • Dianthus Therapeutics was a new Principal Financial Group position in Q2 2026.
  • Dianthus Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2035 holding.
  • Principal Financial Group first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 17 quarters since.
  • Principal Financial Group's Dianthus Therapeutics position peaked at $5.53M in Q2 2018.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.